Development of Novel Biomarkers to Predict REHOSPitalization in Chronic Heart Failure
Not Applicable
- Conditions
- Chronic heart failure
- Registration Number
- JPRN-UMIN000021657
- Lead Sponsor
- ational hospital organization, Kyoto medical center
- Brief Summary
A low sVEGFR-2 value was independently associated with cardiovascular death and all-cause death in patients with chronic HF. These associations were pronounced in those with high NT-proBNP levels.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1065
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with acute coronary syndrome within 14 days 2. Patients who plan to undergo elective revascularization, cardiac surgery, or implantable cardiac device therapy after discharge. 3. Malignancy 4. Inflammatory disease 5. Patients with low drug compliance 6. Inability to give written informed consent 7. Under 20 years old 8. Not eligible in the investigator's opinion
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular death and re-hospitalization for heart failure
- Secondary Outcome Measures
Name Time Method All-cause death Major adverse cardiovascular events Cardiovascular death Re-hospitalization for heart failure All-cause re-hospitalization